Andrew Farlow

Andrew Farlow has worked in global health policy for over twenty-five years, applying a highly interdisciplinary lens that includes life sciences, economics and other social/behavioural sciences, epidemiology, finance, and management research. His goal has been to translate high-quality research into evidence-based practical policies that benefit especially those with very low resources. With degrees in Economics from the Universities of Oxford and Cambridge, he initially focused on the research and development of drugs and vaccines for neglected diseases and on access to medicines, producing a significant body of work on the economics and financing of vaccines and immunisation, especially for malaria, TB, dengue, HPV, and HIV. His work has then broadened to cover early warning systems for disease outbreaks, response to epidemics and pandemics, the burden of dengue, the economic value of vector control, antimicrobial resistance, health system strengthening, One Health, planetary health (including the impact of environment and climate change on health), food and nutrition, medicines derived from natural products, digital health and AI for health, and tools for assessing AI deployment. His work also questions the way global health is ‘done’. and champions greater equity in the research process and in access to the fruits of research.